Literature DB >> 28942490

Susceptibility of mice to bovine herpesvirus type 5 infection in the central nervous system.

L P Mesquita1, R C Costa1, M M Fusuma2, F R P Bruhn3, E Mori4, E M Pituco2, C M C Mori1, R Weiblen5, P C Maiorka6.   

Abstract

Bovine herpesvirus type 5 (BoHV-5) is an important pathogen that causes meningoencephalitis in cattle. Few studies have used the mouse as a model for BoHV-5 infection. Despite the fact that BoHV-5 can infect mice with immune deficiencies, little is known about viral replication, immune response, and the course of infection in the central nervous system (CNS) of wild-type mice. Therefore, the aim of this study was to evaluate the response in the CNS of BALB/c mice acutely infected with BoHV-5 at different days post-inoculation (dpi). BoHV-5, when inoculated intracranially, was able to infect and replicate within the CNS of BALB/c mice. Until 15 dpi, the mice were able to survive without showing prominent neurological signs. The infection was accompanied by a Th1 immune response, with a significant expression of the cytokines IFN-γ and TNF-α and chemokine CCL-2. The expression of these cytokines and chemokines was most significant in the early course of infection (3 and 4 dpi), and it was followed by meningoencephalitis with perivascular cuffing and periventriculitis, composed mainly of macrophages and lymphocytes. After the expression of cytokines and chemokine, the mice were able to curb BoHV-5 acute infection in the brain, since there was a decrease in the number of BoHV-5 DNA copies after 3 dpi and viable viral particles were not detected after 6 dpi. Importantly, BoHV-5 was able to infect the trigeminal ganglia during acute infection, since a large number of BoHV-5 DNA copies were detected on 1 and 2 dpi.

Entities:  

Keywords:  BoHV-5; Brain; Cattle; Encephalitis; Immune response; Trigeminal ganglia

Mesh:

Substances:

Year:  2017        PMID: 28942490     DOI: 10.1007/s11259-017-9699-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  23 in total

1.  Experimental infection of sheep with bovine herpesvirus type-5 (BHV-5): acute and latent infection.

Authors:  A M Silva; R Weiblen; L F Irigoyen; P M Roehe; H J Sur; F A Osorio; E F Flores
Journal:  Vet Microbiol       Date:  1999-04-01       Impact factor: 3.293

2.  Role of the suppressor of cytokine signaling 2 (SOCS2) during meningoencephalitis caused by Bovine herpesvirus 5 (BoHV-5).

Authors:  Aline Aparecida Silva Barbosa; Alice Freitas Versiani; Larissa Fonseca da Cunha Sousa; Aline Silva de Miranda; Marcela Ribeiro Gasparini; Fátima Brant; Daniele Gonçalves Silva; Iracema Luisa Quintino-de-Carvalho; Frederico Marianetti Soriani; Flávio Guimarães da Fonseca; Anilton César Vasconcelos; Lucíola da Silva Barcelos; Mauro Martins Teixeira; Antônio Lúcio Teixeira; Fabiana Simão Machado; Edel Figueiredo Barbosa-Stancioli; Milene Alvarenga Rachid
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2016-05-18       Impact factor: 2.268

3.  TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.

Authors:  T Renno; M Krakowski; C Piccirillo; J Y Lin; T Owens
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

4.  Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

5.  Detection and differentiation of bovine herpesvirus 1 and 5 using a multiplex real-time polymerase chain reaction.

Authors:  Ibrahim S Diallo; Bruce G Corney; Barry J Rodwell
Journal:  J Virol Methods       Date:  2011-04-22       Impact factor: 2.014

6.  Neuropathology of bovine herpesvirus type 5 (BHV-5) meningo-encephalitis in a rabbit seizure model.

Authors:  S I Chowdhury; B J Lee; D Mosier; J H Sur; F A Osorio; G Kennedy; M L Weiss
Journal:  J Comp Pathol       Date:  1997-11       Impact factor: 1.311

7.  Establishment of a rabbit model for bovine herpesvirus type 5 neurological acute infection.

Authors:  G Meyer; M Lemaire; J Lyaku; P P Pastoret; E Thiry
Journal:  Vet Microbiol       Date:  1996-07       Impact factor: 3.293

8.  Bovine herpesvirus-5 infection in a rabbit experimental model: immunohistochemical study of the cellular response in the CNS.

Authors:  Gisele F Machado; Fernanda Bernardi; Fernando Y M Hosomi; Juliana R Peiró; Rudi Weiblen; Paulo M Roehe; Antonio C Alessi; Guilherme D Melo; Adriano T Ramos; Paulo C Maiorka
Journal:  Microb Pathog       Date:  2013-01-29       Impact factor: 3.738

9.  Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression.

Authors:  Ronald B Smeltz; June Chen; Rolf Ehrhardt; Ethan M Shevach
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

10.  Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves.

Authors:  Fernanda Silveira Flôres Vogel; Luizinho Caron; Eduardo Furtado Flores; Rudi Weiblen; Evandro Reinoldo Winkelmann; Sandra Vanderli Mayer; Reginaldo Gaspar Bastos
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

View more
  1 in total

1.  Brain-derived neurotrophic factor is down regulated after bovine alpha-herpesvirus 5 infection in both wild-type and TLR3/7/9 deficient mice.

Authors:  Daniele Gonçalves DA Silva; Iracema Luisa Quintino de Carvalho; Eliana Cristina de Brito Toscano; Beatriz Álvares da Silva Senra Santos; Bruna da Silva Oliveira; Marco Antônio Campos; Flávio Guimarães da Fonseca; Quezya Mendes Camargos; Gabriela Ferreira de Sousa; Marcelo Vidigal Caliari; Antônio Lúcio Teixeira; Aline Silva de Miranda; Milene Alvarenga Rachid
Journal:  J Vet Med Sci       Date:  2020-12-07       Impact factor: 1.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.